Assyro AI

Orange Book product · Brand (NDA)

TRELSTAR

TRIPTORELIN PAMOATE

Brand (NDA)NDA 022437RX VERITY

At a glance

Mar 10, 2010

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 10, 2010

    16 yr 6 mo ago

  2. Today

  3. Patent 10166181 expires

    Listed drug product patent expiration.

    Jun 30, 2029

    in 3 yr 1 mo

Pharmaceutical detail

Active ingredient

TRIPTORELIN PAMOATE

Strength

EQ 22.5MG BASE/VIAL

Dosage form

INJECTABLE

Route

INTRAMUSCULAR

TE code

Not listed

Application

NDA 022437

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10166181Jun 30, 2029in 3 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.